FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Esomeprazole Strontium submitted by R2 Pharma, LLC under NDA202342.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nonerosive Reflux Disease

Drugs mentioned

• Esomeprazole strontium (Esomeprazole strontium)

Snippet

SUPPL AP for ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)